M. Egger

Chlamydia pneumoniae in coronary artery disease.

B. Horne, J. Carlquist, C. Nielson, 2000, Circulation.

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.

B. Horne, J. Carlquist, C. Nielson, 1999, Circulation.

S100A1ct: a synthetic peptide derived from human S100A1 protein improves cardiac contractile performance and survival in pre-clinical heart failure models

R. Wade, M. Völkers, W. Koch, 2023, bioRxiv.